Factors influencing adherence in CML and ways to improvement:
Results from a patient-driven survey of 2,546 patients in 63 countries
Jana Pelouchová, European Cancer Patient Coalition (ECPC), Czech Republic 

• CML Advocates Network: Patients creating scientific evidence
• Why this study?
• Where are we now?
• Truly global research: 2,546 patients from 63 countries
• Validated adherence scales to classify patients into levels of adherence
• Results on adherence levels
• What can we do to drive adherence?
• Conclusions